Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using CRISPR to understand how cancer mutations happen.

Communications biology - 23 Jun 2021

Rogers Eve H

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neoplasms
Share to Mutation
Share to Brain Neoplasms
Share to Clustered Regularly Interspaced Short Palindromic Repeats

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Gene Editing

Share to Neoplastic Syndromes, Hereditary

Source

Open in PubMed Open full text

Identifiers

PMID: 34162994
DOI: 10.1038/s42003-021-02313-9
PMCID: PMC8222223

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using CRISPR to understand how cancer mutations happen.PMID 34162994Read ↗

Using CRISPR-Cas9 to Dissect Cancer Mutations in Cell Lines.Semantic proximity Read ↗

Let's make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment.Semantic proximity Read ↗

CRISPR base editing applications for identifying cancer-driving mutations.Semantic proximity Read ↗

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy.Semantic proximity Read ↗

DNA Prime Editing: A New CRISPR-Based Method to Correct Most Disease-Causing Mutations.Semantic proximity Read ↗

Surprising CRISPR roadblocks.Semantic proximity Read ↗

CRISPR/Cas9 for Cancer Therapy: Hopes and ChallengesSemantic proximity Read ↗

Genome editing: CRISPR-Cas becoming more human.Semantic proximity Read ↗

Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future ResearchSemantic proximity Read ↗

The CRISPR-Cas system in molecular diagnosticsSemantic proximity Read ↗

Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and ChallengesSemantic proximity Read ↗

Precision targeting tumor cells using cancer-specific InDel mutations with CRISPR-Cas9Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.